115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter

Adeno associated virus undergoes Rep-mediated integration into the AAV-S1 region of human chromosome 19 during latent infection but recombinant AAV (rAAV) vectors are missing essential viral components and lack such site-specificity. This was best shown recently by strategies that monitor rAAV integ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular therapy 2006-05, Vol.13 (S1), p.S47
Hauptverfasser: Drew, Horace R., Lockett, Linda J., Both, Gerald W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue S1
container_start_page S47
container_title Molecular therapy
container_volume 13
creator Drew, Horace R.
Lockett, Linda J.
Both, Gerald W.
description Adeno associated virus undergoes Rep-mediated integration into the AAV-S1 region of human chromosome 19 during latent infection but recombinant AAV (rAAV) vectors are missing essential viral components and lack such site-specificity. This was best shown recently by strategies that monitor rAAV integration events at the level of the whole eukaryotic genome. However, whole-genome analyses have not been used to analyse integration by wild-type AAV. We have used ligation-mediated PCR (LM-PCR) to monitor AAV integration under both latent and replication-permissive conditions of infection. Sequence analysis of fifty-two clones that met pre-determined criteria showed that, during replication, AAV integrated into many chromosomal sites via sequence microhomology that frequently involved a GGTC motif located within the AAV p5 element, with one site preferred. No clones containing specific AAV/AAV-S1 junctions were identified among authentic LM-PCR clones, although such clones were readily obtained using junction-specific PCR primers; suggesting that AAV-S1 integration events constituted only a small portion of the total integration product. During latent AAV infection, GGTC-mediated integration was significantly reduced, but such micro-homology-determined chromosomal junctions were still obtained in excess over AAV-S1 specific products. This new mechanism for the integration of AAV sequences into human chromosomes has a "signature" that suggests it may occur independently of Rep, although the detailed mechanism remains to be elucidated. Finally, since others have shown that the p5 element is necessary and sufficient for AAV-S1 chromosomal integration, in view of our new findings, the specificity of new rAAV vectors that include p5-region sequences for improved Repmediated integration should be closely monitored, especially by whole-genome approaches.
doi_str_mv 10.1016/j.ymthe.2006.08.135
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1792804891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4073983951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1175-ec70113fa9c21ec223e77a779448f9118b389f74ee09361b3eb349862816fd603</originalsourceid><addsrcrecordid>eNpFUctuwjAQjKpWKqX9gl4s9ZzUG-dhHxEqD4kKJGh7tEzYkKAQUzsI5bP6h3UAtaddeXZnZj2e9ww0AArJ6y5o902BQUhpElAeAItvvB7EYexTGka3fz0k996DtTvXQSySnvfjakC-Cl0hGWOt90gGtapaW1qyLPTJklWhGjIYfJJp3eDWqAYtcS_Dwui9tt0CiA73l0CW5RmtN2Tu7Jj_IVVdsTPbyOD3Eeumap2GMk55vBqS9zIz2p-4hUpvW3Iqm4I4lrP2IiaLjqpB8-jd5aqy-HStfe9j9LYaTvzZfDwdDmZ-BpDGPmapu5HlSmQhYBaGDNNUpamIIp4LAL5mXORphEgFS2DNcM0iwZOQQ5JvEsr63suF92C0c2sbudNH4_7GSkhFyGnEBbgpdply3q01mMuDKffKtBKo7LKRO3nORnbZSMqly4b9As4mgew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1792804891</pqid></control><display><type>article</type><title>115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Drew, Horace R. ; Lockett, Linda J. ; Both, Gerald W.</creator><creatorcontrib>Drew, Horace R. ; Lockett, Linda J. ; Both, Gerald W.</creatorcontrib><description>Adeno associated virus undergoes Rep-mediated integration into the AAV-S1 region of human chromosome 19 during latent infection but recombinant AAV (rAAV) vectors are missing essential viral components and lack such site-specificity. This was best shown recently by strategies that monitor rAAV integration events at the level of the whole eukaryotic genome. However, whole-genome analyses have not been used to analyse integration by wild-type AAV. We have used ligation-mediated PCR (LM-PCR) to monitor AAV integration under both latent and replication-permissive conditions of infection. Sequence analysis of fifty-two clones that met pre-determined criteria showed that, during replication, AAV integrated into many chromosomal sites via sequence microhomology that frequently involved a GGTC motif located within the AAV p5 element, with one site preferred. No clones containing specific AAV/AAV-S1 junctions were identified among authentic LM-PCR clones, although such clones were readily obtained using junction-specific PCR primers; suggesting that AAV-S1 integration events constituted only a small portion of the total integration product. During latent AAV infection, GGTC-mediated integration was significantly reduced, but such micro-homology-determined chromosomal junctions were still obtained in excess over AAV-S1 specific products. This new mechanism for the integration of AAV sequences into human chromosomes has a "signature" that suggests it may occur independently of Rep, although the detailed mechanism remains to be elucidated. Finally, since others have shown that the p5 element is necessary and sufficient for AAV-S1 chromosomal integration, in view of our new findings, the specificity of new rAAV vectors that include p5-region sequences for improved Repmediated integration should be closely monitored, especially by whole-genome approaches.</description><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1016/j.ymthe.2006.08.135</identifier><language>eng</language><publisher>Milwaukee: Elsevier Limited</publisher><subject>Chromosomes ; Cloning ; Gene therapy ; Genomes ; Infections ; Kinases ; Liver ; Medicine ; Vectors (Biology)</subject><ispartof>Molecular therapy, 2006-05, Vol.13 (S1), p.S47</ispartof><rights>Copyright Nature Publishing Group May 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1792804891?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,64364,64368,72218</link.rule.ids></links><search><creatorcontrib>Drew, Horace R.</creatorcontrib><creatorcontrib>Lockett, Linda J.</creatorcontrib><creatorcontrib>Both, Gerald W.</creatorcontrib><title>115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter</title><title>Molecular therapy</title><description>Adeno associated virus undergoes Rep-mediated integration into the AAV-S1 region of human chromosome 19 during latent infection but recombinant AAV (rAAV) vectors are missing essential viral components and lack such site-specificity. This was best shown recently by strategies that monitor rAAV integration events at the level of the whole eukaryotic genome. However, whole-genome analyses have not been used to analyse integration by wild-type AAV. We have used ligation-mediated PCR (LM-PCR) to monitor AAV integration under both latent and replication-permissive conditions of infection. Sequence analysis of fifty-two clones that met pre-determined criteria showed that, during replication, AAV integrated into many chromosomal sites via sequence microhomology that frequently involved a GGTC motif located within the AAV p5 element, with one site preferred. No clones containing specific AAV/AAV-S1 junctions were identified among authentic LM-PCR clones, although such clones were readily obtained using junction-specific PCR primers; suggesting that AAV-S1 integration events constituted only a small portion of the total integration product. During latent AAV infection, GGTC-mediated integration was significantly reduced, but such micro-homology-determined chromosomal junctions were still obtained in excess over AAV-S1 specific products. This new mechanism for the integration of AAV sequences into human chromosomes has a "signature" that suggests it may occur independently of Rep, although the detailed mechanism remains to be elucidated. Finally, since others have shown that the p5 element is necessary and sufficient for AAV-S1 chromosomal integration, in view of our new findings, the specificity of new rAAV vectors that include p5-region sequences for improved Repmediated integration should be closely monitored, especially by whole-genome approaches.</description><subject>Chromosomes</subject><subject>Cloning</subject><subject>Gene therapy</subject><subject>Genomes</subject><subject>Infections</subject><subject>Kinases</subject><subject>Liver</subject><subject>Medicine</subject><subject>Vectors (Biology)</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpFUctuwjAQjKpWKqX9gl4s9ZzUG-dhHxEqD4kKJGh7tEzYkKAQUzsI5bP6h3UAtaddeXZnZj2e9ww0AArJ6y5o902BQUhpElAeAItvvB7EYexTGka3fz0k996DtTvXQSySnvfjakC-Cl0hGWOt90gGtapaW1qyLPTJklWhGjIYfJJp3eDWqAYtcS_Dwui9tt0CiA73l0CW5RmtN2Tu7Jj_IVVdsTPbyOD3Eeumap2GMk55vBqS9zIz2p-4hUpvW3Iqm4I4lrP2IiaLjqpB8-jd5aqy-HStfe9j9LYaTvzZfDwdDmZ-BpDGPmapu5HlSmQhYBaGDNNUpamIIp4LAL5mXORphEgFS2DNcM0iwZOQQ5JvEsr63suF92C0c2sbudNH4_7GSkhFyGnEBbgpdply3q01mMuDKffKtBKo7LKRO3nORnbZSMqly4b9As4mgew</recordid><startdate>20060501</startdate><enddate>20060501</enddate><creator>Drew, Horace R.</creator><creator>Lockett, Linda J.</creator><creator>Both, Gerald W.</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20060501</creationdate><title>115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter</title><author>Drew, Horace R. ; Lockett, Linda J. ; Both, Gerald W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1175-ec70113fa9c21ec223e77a779448f9118b389f74ee09361b3eb349862816fd603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Chromosomes</topic><topic>Cloning</topic><topic>Gene therapy</topic><topic>Genomes</topic><topic>Infections</topic><topic>Kinases</topic><topic>Liver</topic><topic>Medicine</topic><topic>Vectors (Biology)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Drew, Horace R.</creatorcontrib><creatorcontrib>Lockett, Linda J.</creatorcontrib><creatorcontrib>Both, Gerald W.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Drew, Horace R.</au><au>Lockett, Linda J.</au><au>Both, Gerald W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter</atitle><jtitle>Molecular therapy</jtitle><date>2006-05-01</date><risdate>2006</risdate><volume>13</volume><issue>S1</issue><spage>S47</spage><pages>S47-</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><abstract>Adeno associated virus undergoes Rep-mediated integration into the AAV-S1 region of human chromosome 19 during latent infection but recombinant AAV (rAAV) vectors are missing essential viral components and lack such site-specificity. This was best shown recently by strategies that monitor rAAV integration events at the level of the whole eukaryotic genome. However, whole-genome analyses have not been used to analyse integration by wild-type AAV. We have used ligation-mediated PCR (LM-PCR) to monitor AAV integration under both latent and replication-permissive conditions of infection. Sequence analysis of fifty-two clones that met pre-determined criteria showed that, during replication, AAV integrated into many chromosomal sites via sequence microhomology that frequently involved a GGTC motif located within the AAV p5 element, with one site preferred. No clones containing specific AAV/AAV-S1 junctions were identified among authentic LM-PCR clones, although such clones were readily obtained using junction-specific PCR primers; suggesting that AAV-S1 integration events constituted only a small portion of the total integration product. During latent AAV infection, GGTC-mediated integration was significantly reduced, but such micro-homology-determined chromosomal junctions were still obtained in excess over AAV-S1 specific products. This new mechanism for the integration of AAV sequences into human chromosomes has a "signature" that suggests it may occur independently of Rep, although the detailed mechanism remains to be elucidated. Finally, since others have shown that the p5 element is necessary and sufficient for AAV-S1 chromosomal integration, in view of our new findings, the specificity of new rAAV vectors that include p5-region sequences for improved Repmediated integration should be closely monitored, especially by whole-genome approaches.</abstract><cop>Milwaukee</cop><pub>Elsevier Limited</pub><doi>10.1016/j.ymthe.2006.08.135</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-0016
ispartof Molecular therapy, 2006-05, Vol.13 (S1), p.S47
issn 1525-0016
1525-0024
language eng
recordid cdi_proquest_journals_1792804891
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection
subjects Chromosomes
Cloning
Gene therapy
Genomes
Infections
Kinases
Liver
Medicine
Vectors (Biology)
title 115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A47%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=115.%20Whole%20Genome%20Analysis%20Shows%20That%20AAV%20Integrates%20at%20Chromosome%2019%20AAV-S1%20Sites%20and%20Other%20Chromosomal%20Sites%20That%20Frequently%20Share%20GGTC%20Micro-Homology%20with%20the%20AAV%20P5%20Promoter&rft.jtitle=Molecular%20therapy&rft.au=Drew,%20Horace%20R.&rft.date=2006-05-01&rft.volume=13&rft.issue=S1&rft.spage=S47&rft.pages=S47-&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1016/j.ymthe.2006.08.135&rft_dat=%3Cproquest_cross%3E4073983951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1792804891&rft_id=info:pmid/&rfr_iscdi=true